About MindWave Medical
MindWave Medical is developing an alarm-routing system for hospitals. It sends eligible equipment alerts to the responsible caregiver through a bone-conduction headset, while critical or unclaimed alarms stay audible.
The Knoxville company was founded in 2023 and is not yet approved for sale. Its DECIBEL study covered 311 patients in two Indian ICUs, and the FDA granted STeP designation.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | May 5, 2025amended Oct 26, 2026 | $880,000of $5.0M target | 17 | $51,765 | SAFEsRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Why Investors Backed MindWave Medical
MindWave is addressing a familiar hospital problem with a focused hardware and software system. It routes eligible alarms to the responsible caregiver instead of broadcasting every alert across a unit. The team brings clinical, engineering and aviation-safety experience. The company has also completed a clinical study and entered an FDA program for safety-focused devices.
The problem it targets
Hospital equipment alarms must be loud enough to reach staff, so patients and caregivers hear many alerts that do not require their action. MindWave's view is that this noise contributes to alarm fatigue, disrupted sleep, delirium risk and staff burnout. It also makes it harder for caregivers to identify which alert belongs to them.
What the product does
MindWave sends eligible alarms to a lightweight bone-conduction headset worn by the responsible caregiver. The system checks equipment location and staff availability before routing an alert. Life-threatening alarms remain audible, and every routed alert has an audible backup if nobody accepts it. The product is designed for the open IEEE 11073 SDC interoperability standard.
Progress so far
MindWave's DECIBEL study tested the system with 311 patients in two ICUs in India. The results are still under peer review. It also has a granted U.S. patent, FDA Safer Technologies Program designation and selection for the 2026 Project Healthcare accelerator. It has not named paying customers or reported revenue.
How the market is moving
The FDA's Safer Technologies Program gives qualifying devices more frequent interaction with the agency during development and review. MindWave is also building for IEEE 11073 SDC, an open standard intended to let medical devices exchange information. Those paths may help hospital alarm systems connect with existing equipment, but they do not replace clearance.
We wrote this summary from public statements by MindWave Medical and its investors. It is not investment advice.
MindWave Medical in the News
Leadership Team
Executive officers and directors listed on MindWave Medical's Form D filed Oct 26, 2026.
